Enjoy complimentary customisation on priority with our Enterprise License!
The intragastric balloons market size has the potential to grow by USD 144.87 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.
This report provides a detailed analysis of the market by product (insertable balloons and swallowable balloons) and geography (North America, APAC, Europe, South America, and MEA). Also, the report analyzes the market’s competitive landscape. It offers information on several market vendors, including Allurion Technologies Inc., Apollo Endosurgery Inc., Districlass Medical SA, Duomed Group, Endalis, Fengh Medical Co. Ltd., Lexel Srl, Obalon Therapeutics Inc., Silimed, and Spatz FGIA Inc.
The intragastric balloons market is concentrated. Increasing preference for minimally invasive techniques will provide ample growth opportunities to market vendors. Fengh Medical Co. Ltd., Lexel Srl, Obalon Therapeutics Inc., Silimed, and Spatz FGIA Inc. are some of the major market participants. Although the cost-effectiveness and safety of intragastric balloon will offer immense growth opportunities, complications associated with intragastric balloon treatment will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this intragastric balloons market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this intragastric balloons market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading companies, including:
North America was the largest intragastric balloons market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The high prevalence of obesity will significantly influence intragastric balloons market growth in this region.
Over 36% of the market’s growth will originate from North America during the forecast period. The US is the critical market for intragastric balloons in North America. Market growth in this region will be slower than the growth of the market in APAC and Europe.
The insertable balloons segment is the major revenue contributor to the global intragastric balloons market due to the availability of many endoscopically insertable intragastric balloons in the market and its increasing popularity in the developing economies.
Market growth in this segment will be faster than the growth of the market in the swallowable balloons segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the intragastric balloons market size.
The cost-effectiveness and safety of intragastric balloons will have a significant influence on market growth. The intragastric balloon implantation procedures are safer and lower cost alternatives to bariatric surgery, which is an invasive weight loss procedure that poses various post-surgical complications. The cost of these procedures is also significantly higher than the intragastric balloon plantation. Hence, there is growing popularity of non-surgical and less-invasive weight loss treatments such as intragastric balloon implantation.
The growing focus of vendors on technological advances, one of the critical intragastric balloon market trends, will also drive market growth. Various leading vendors are focusing on enhancing the capabilities and efficiency of intragastric balloon devices. Manufacturers are also working on the adjustments of the balloon volume and longer implantation time. Minimally invasive procedures are available to implant the intragastric balloon, which can be easily performed in an outpatient set up. An intragastric balloon can be placed through a simple endoscopic method, and it is easily reversible. The advancements in the properties of the intragastric balloon and procedural techniques are influencing vendors to develop innovative and cost-effective products, driving market growth at a CAGR of over 23% during the forecast period.
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.